A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor

Medical Device News Magazine is committed to delivering high‑quality, in‑depth medical device news and biotechnology updates that include expert bylines. Our coverage offers a comprehensive view of the trends, innovations, and breakthroughs shaping the future of medical technology.

We also strive to provide a distinctive perspective on the rapidly evolving healthcare landscape. By staying connected with our reporting, you gain access to exclusive insights on industry developments, emerging technologies, and global regulatory changes that influence the medical device sector. At the same time, you join a vibrant community of professionals, innovators, and thought leaders dedicated to advancing healthcare through cutting‑edge solutions.

We invite you to explore our wide range of content—from the latest product announcements to detailed analyses of industry trends. And if our mission aligns with your goals, we offer opportunities for advertising and collaboration, helping you connect with a highly engaged audience of medical technology professionals.

Definition medical devices.

Medical Device Industry News | Latest Developments, Breakthroughs & Future Outlook

Latest News

Ellipsys Vascular Access System to Return to U.S. Market in 2026

Ellipsys Vascular Access System to Return to U.S. Market in 2026

Ellipsys Medical, Inc. today announced that the Ellipsys® Vascular Access System will once again be commercially available, with initial availability anticipated in mid-2026. The announcement marks the planned reintroduction of the minimally invasive technology to clinicians and patients following a period of limited market availability. The Ellipsys System, previously available...

Clinical Trials

ProStyle M® Transcatheter Mitral Valve System

First Implant of KingstronBio’s ProStyle M® Transcatheter Mitral Valve System Successfully Completed in National Multicenter Confirmatory Study

On March 12, 2026, the first implant of the ProStyle M® Transcatheter Mitral Valve System (ProStyle M®) was successfully completed under pure ultrasound guidance as part of its confirmatory clinical study. The device is independently developed by KingstronBio Technology (Changshu) Co., Ltd. (KingstronBio). The procedure was performed by Professor Wang Chunsheng and Professor...

Biotechnology News

Mergers & Acquisitions

Funding

Industry Expert Bylines

Postpartum Hemorrhage

The Role of Endovascular Specialists in the Multidisciplinary Approach to Postpartum Hemorrhage | By Dr. Adam Power, Co-Founder and CMO, Front Line Medical Technologies

Postpartum hemorrhage (PPH) continues to challenge obstetric care despite ongoing medical advancements. With blood loss exceeding 500 ml in 6.3% to 13% of births and over 1000 ml in 1.9% to 2.8% of cases, PPH remains a significant concern. These figures are particularly worrying given that 500 ml is the established threshold for PPH following vaginal delivery. Cesarean sections often involve even more significant blood loss, frequently exceeding 1000 ml.

Type 2 CGM Hardware

Transforming Diabetes Care: Why CGM Hardware Must Evolve for the Type 2 Population | By Dr. Chris Dawson, Head of Biosensing at TTP

The landscape of diabetes management is transforming, as continuous glucose monitoring (CGM) devices expand beyond Type 1 diabetes and into a rapidly growing Type 2 market. Changes to regulatory approvals and insurance coverage driven by improved patient outcomes have opened the door for non-insulin-dependent Type 2 patients to access CGM. Device manufacturers now face a new frontier: designing CGM hardware that meets the unique needs of an increasingly diverse patient population. For CGMs to realize their full potential in Type 2 diabetes management, it’s critical to rethink hardware design to cater to this population’s distinct requirements, improving usability, flexibility, and the quality of care.

FDA Medical Device Updates

Market Reports

Executives

Advancements In Imaging

MAUI Imaging Emerges From Stealth With $4 Million Department of Defense Contract To Support Trauma Medicine

MAUI Imaging CEO and co-founder David Specht. “The feedback we have received from physicians and technologists highlights the profound need for a new ultrasound-based technology that enables imaging of all types of tissues. That need is most pronounced in trauma medicine, which is a major focus of MAUI’s collaborative development efforts.  Going forward, MAUI will be able to supply the volumetric imaging data for AI tools that predominantly come from CT and MRI.”

Life Molecular Imaging and PharmaLogic announce Neuraceq® availability in Denver

“By partnering with PharmaLogic and offering Neuraceq® in Denver, Life Molecular Imaging is excited to expand access of Neuraceq® for the detection of beta-amyloid plaques in the brain. We believe this additional access benefits physicians and patients, as well as our pharma partners for routine clinical and research use. We are excited to collaborate with Pharmalogic today and look forward to more opportunities in the future. ” said Ludger Dinkelborg, Ph.D., Managing Director at LMI.

Carilion Clinic

Carilion Clinic Further Expands Quality Cardiac Care Access with Latest Philips Innovations at New Regional Cardiovascular Institute in Virginia, US

“At Carilion Clinic, we are committed to improving the health of the communities we serve. We know that collaboration is an essential component to realizing this vision,” said Marguerite Underwood, Vice President for the Carilion Clinic Cardiovascular Institute. “Working with Philips ensures that we will be able to set the standard in cardiovascular care, not only today, but well into the future.”

Hospitals In the News

Non-Profit News

Healthcare: Understanding the Business Side of the Industry and Its Implications

Healthcare Careers

Nurses Corner

Health: A Comprehensive Exploration of Wellness, Nutrition, and Overall Well-Being for a Healthier Life

Articles Designed to Inspire and Guide You Toward Achieving Excellence and Success in All Your Endeavors.